During the past decade, Oita Prefectural Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oita Prefectural Hospital" #1 sponsor was "Bayer" with 3 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Kyowa Kirin Co., Ltd." with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Japan Clinical Cancer Research Organization" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oita Prefectural Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Japan Blood Products Organization" with 1 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Oita Prefectural Hospital" are "Acute Myocardial Infarction" (1 trials), "Adult T-cell Leukemia-Lymphoma" (1 trials), "Alzheimer Disease" (1 trials), "Atrial Fibrillation" (1 trials) and "Extensive Disease Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Oita Prefectural Hospital" in a lesser frequency.

Most popular intervention types in "Oita Prefectural Hospital" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Antithrombin gamma" (1 trials), "Any approved or standard-of-care therapy" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oita Prefectural Hospital" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oita Prefectural Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Oita Prefectural Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oita Prefectural Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".